{{Rsnum
|rsid=6852535
|Chromosome=4
|position=122557561
|Orientation=plus
|GMAF=0.247
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 50.4 | 47.8
| HCB | 6.6 | 44.5 | 48.9
| JPT | 6.2 | 42.5 | 51.3
| YRI | 0.0 | 4.1 | 95.9
| ASW | 0.0 | 8.8 | 91.2
| CHB | 6.6 | 44.5 | 48.9
| CHD | 13.8 | 44.0 | 42.2
| GIH | 17.8 | 57.4 | 24.8
| LWK | 0.0 | 10.9 | 89.1
| MEX | 12.1 | 43.1 | 44.8
| MKK | 1.9 | 37.2 | 60.9
| TSI | 6.9 | 48.0 | 45.1
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21685912
|Trait=None
|Title=Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.
|RiskAllele=
|Pval=1E-7
|OR=1.2300
|ORtxt=[1.13-1.32]
|OA=1
}}

{{PMID Auto
|PMID=17558408
|Title=A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}